Optic Neuritis Recruiting Phase 2 / 3 Trials for Methylprednisolone (DB00959)

Also known as: Optical Neuritis / Unspecified optic neuritis / Optic neuritis NOS / Optic neuritis, unspecified / Neuritis optic

IndicationStatusPhase
DBCOND0027863 (Optic Neuritis)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04942002Retrobulbar Methylprednisolone as Adjunctive Treatment in Optic Neuritis TrialTreatment